Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer.
Anna Z de BoerEsther BastiaannetNienke A de GlasPerla J Marang-van de MheenOlaf M DekkersSabine SieslingLinda de MunckKelly M de LigtJohanneke E A PortieljeGerrit Jan LiefersPublished in: Breast cancer research and treatment (2019)
Despite endocrine treatment in only 39.3%, locoregional recurrence risk was low, even in patients treated at hospitals with lower radiotherapy-use. This provides reasonable grounds to consider omission of radiotherapy in patients aged ≥ 75 years with T1-2N0 breast cancer.
Keyphrases
- early stage
- locally advanced
- end stage renal disease
- radiation therapy
- radiation induced
- ejection fraction
- chronic kidney disease
- newly diagnosed
- minimally invasive
- healthcare
- neoadjuvant chemotherapy
- systematic review
- prognostic factors
- squamous cell carcinoma
- peritoneal dialysis
- coronary artery bypass
- coronary artery disease
- rectal cancer
- free survival
- patient reported outcomes
- smoking cessation
- surgical site infection